On November 17, 2015, TheGrantLawFirm, PLLC disseminated a notice to shareholders under the PSLRA, announcing that it filed a class action complaint (“Complaint”) on behalf of all securities holders who purchased securities of Spectrum Pharmaceuticals, Inc. (SPPI: NASDAQ)(“Spectrum” or the “Company”) during the period between May 7, 2015 until October 23, 2015, inclusive (the “Class Period”). Since the publication of the PSLRA notice, TheGrantLawFirm, PPLC has withdrawn the complaint.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151215006585/en/
Contacts:
Lynda J. Grant, Esq.
Telephone:
212-292-4441
Facsimile: 212-292-4446
lgrant@grantfirm.com